Some epidemiological aspects of drug-treated intraocular hypertension in Belgium were established in 1992 from questionnaires filled in by 1513 patients who attended a sample of 209 pharmacies open to the public.
The mean age of the patients was 67 years (range : 3-95).
After standardization for age, the prevalence of diabetes mellitus among patients was found to be 1.7 times higher than in the general population.
Family history of glaucoma and/or blindness was reported by 28% of the patients.
Beta-blocker eye drops were used by 96% of the sample.
An ophthalmologist was consulted more than four times a year by 24% of the patients who had been drug-treated for less than one year ; the proportion, however, decreases to 11% for those treated for at least five years.
The annual consumed dose of eye drops containing parasympathomimetics, beta-blockers, and epinephrine or dipivefrine was 12.4,13.6, and 12.3 bottles, respectively, and that of ointments containing parasympathomimetics was 9.9 tubes.
From these results and using sales figures, the prevalence of drug-treated intraocular hypertension was found to be 77 per 10,000 inhabitants (95% CI : 31-123).
Mots-clés Pascal : Glaucome, Tonus oculaire, Médicament, Parasympathomimétique, Bloquant bêta-adrénergique, Adrénaline, Dipivéfrine, Epidémiologie, Toxicité, Homme, Belgique, Europe, Oeil pathologie
Mots-clés Pascal anglais : Glaucoma (eye), Intraocular pressure, Drug, Parasympathomimetic, Beta blocking agent, Epinephrine, Epidemiology, Toxicity, Human, Belgium, Europe, Eye disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0420260
Code Inist : 002B02U09. Création : 10/04/1997.